VEGFA and hereditary clear cell renal cell carcinoma: Vascular endothelial growth factor (VEGF) inhibitors prevent activation of cellular processes promoting angiogenesis and are commonly used in the treatment for renal cell carcinoma as well as metastatic colon and gastric cancer [108].